No definition available.
Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere
EFO MESH Endpoint Browser PheWeb
F5_PHYSBEHOTH
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
636 |
4. Check minimum number of eventsNone |
636 |
5. Include endpointsNone |
636 |
6. Filter based on genotype QC (FinnGen only) |
636 |
Control definitions (FinnGen only)
- Control exclude
- F5_BEHAVE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Behavioural syndromes associated with physiological disturbances and physical factors
- Any mental disorder
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4724 | 2748 | 1950 |
| Only index persons | 4145 | 2451 | 1694 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.08 | 0.05 |
| Only index persons | 0.08 | 0.09 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 29.95 | 34.14 | 23.70 |
| Only index persons | 28.04 | 32.65 | 21.36 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 636 | 414 | 222 |
| Unadjusted period prevalence (%) | 0.13 | 0.14 | 0.10 |
| Median age at first event (years) | 33.44 | 33.57 | 33.20 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 576
- Matched controls
- 5757
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
+∞
323.0
511
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
7.7
80.7
219
426
3160A
ICD-9 Finland
Psychic factors associated with diseases classified elsewhere[PSYYK TEKIJÄT ORGAANISTEN SAIRAUKSIEN/OIREIDEN YHTE]
+∞
68.1
64
*
Z3226
NOMESCO Finland
Physiotherapist
4.5
51.0
228
734
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
7.7
50.6
127
204
H04AA01
ATC
glucagon; nasal, parenteral
9.9
47.3
100
120
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
7.6
46.1
116
185
ZY010
NOMESCO Finland
Hospital outpatient
6.9
45.2
122
215
Z3231
NOMESCO Finland
Registered nurse
3.7
45.0
278
1162
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
10.5
42.4
86
95
T89
ICPC
Diabetes insulin dependent
8.3
41.5
97
137
103
Kela drug reimbursment
Diabetes, insulin-treated
4.1
40.8
192
624
A10AE05
ATC
insulin detemir; parenteral
7.5
40.7
102
160
N03AX16
ATC
pregabalin; oral
4.1
39.6
183
583
215
Kela drug reimbursment
Diabetes, non-insulin-treated
4.0
37.7
181
593
Z2446
NOMESCO Finland
Social worker
4.8
37.7
140
358
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
6.6
36.9
101
179
A10AE04
ATC
insulin glargine; parenteral
6.1
35.0
103
200
Z2445
NOMESCO Finland
Psychologist
5.2
33.0
112
257
N06AX21
ATC
duloxetine; oral
5.1
32.5
111
256
ZXE10
NOMESCO Finland
More than one and less than three hours
3.0
32.1
274
1350
N06AX11
ATC
mirtazapine; oral
3.2
31.2
218
931
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
9.1
31.0
67
82
N03AX12
ATC
gabapentin; oral
4.3
29.9
125
352
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
11.4
29.9
57
55
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.9
28.4
134
420
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.2
26.9
111
307
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.9
26.8
93
216
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.1
26.4
175
707
Z3229
NOMESCO Finland
Other healthcare associate professional
4.3
26.0
105
284
R4110
NOMESCO Finland
Physiotherapy
2.9
26.0
202
905
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.6
25.8
97
244
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
12.7
25.7
46
39
N05BA04
ATC
oxazepam; oral
3.1
25.2
170
692
N02AX02
ATC
tramadol; systemic, rectal
2.7
24.9
234
1170
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
6.0
24.8
71
131
N05AH04
ATC
quetiapine; oral
3.4
24.5
139
499
C03CA01
ATC
furosemide; systemic
3.3
24.3
140
507
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
5.4
24.3
77
161
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.9
24.2
84
194
N02AA05
ATC
oxycodone; systemic
4.2
24.2
99
270
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
9.5
24.1
50
57
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
5.0
24.0
81
182
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
7.5
24.0
58
85
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
8.3
23.9
54
71
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.7
23.8
113
352
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
7.4
23.8
58
86
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
15.4
23.8
39
27
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
23.6
225
1128
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.1
23.6
100
282
R51.80
ICD-10 Finland
Headache
3.1
23.2
146
562
N06AB03
ATC
fluoxetine; oral
3.8
22.8
106
324
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
9.4
22.5
47
54
N03AE01
ATC
clonazepam; systemic
6.4
22.5
61
105
H3603, E103
ICD-10 Finland
NA
15.1
22.4
37
26
RD210
NOMESCO Finland
NA
5.5
22.2
68
136
TBW99
NOMESCO Finland
Other minor procedure in endocrine surgery
9.9
22.2
45
49
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
7.2
22.0
54
81
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
21.7
155
647
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
18.3
21.6
33
19
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.9
21.5
153
635
E10
ICD-10 Finland
Type 1 diabetes mellitus
8.6
21.4
47
59
Z01.8
ICD-10 Finland
Other specified special examinations
2.8
21.3
164
716
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
4.7
21.1
75
177
ZXD10
NOMESCO Finland
Scheduled procedure
2.4
21.1
269
1550
N06AA09
ATC
amitriptyline; systemic
4.4
21.0
81
208
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.7
20.8
175
803
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.4
20.8
263
1507
Z2221
NOMESCO Finland
Medical doctor
2.5
20.5
212
1090
A10AA02
ATC
NA
8.3
20.2
45
58
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.8
20.2
150
639
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
5.5
20.1
61
121
ZXE00
NOMESCO Finland
One hour or less
2.3
20.0
284
1713
R50.9
ICD-10 Finland
Fever, unspecified
3.0
19.9
134
536
J01FF01
ATC
clindamycin; systemic
2.6
19.6
171
800
A10AA01
ATC
NA
8.1
19.5
44
58
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
23.5
19.2
27
12
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
7.5
19.0
45
64
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
6.3
18.6
50
85
R4190
NOMESCO Finland
Nutritional therapy
4.3
18.6
73
190
XCK10
NOMESCO Finland
Photography of fundus of eye
4.0
18.4
78
218
N06AB10
ATC
escitalopram; oral
2.6
18.4
153
693
A03FA01
ATC
metoclopramide; systemic, rectal
2.8
18.3
131
542
N03AX09
ATC
lamotrigine; oral
4.8
18.2
63
145
ZXD05
NOMESCO Finland
Urgent procedure
2.3
18.1
212
1147
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
9.8
17.9
36
39
N03AF01
ATC
carbamazepine; oral, rectal
6.0
17.8
50
90
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.7
17.8
63
148
N05BA01
ATC
diazepam; systemic, rectal
3.4
17.7
93
311
N06AX16
ATC
venlafaxine; oral
3.1
17.6
106
389
N06AB04
ATC
citalopram; systemic
2.8
17.5
132
560
L04AA06
ATC
mycophenolic acid; systemic
9.3
17.4
36
41
L28
ICPC
Limited function/disability (L)
3.3
17.3
96
333
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
5.3
17.3
54
111
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
5.1
16.9
54
114
XF400
NOMESCO Finland
ECG with 12 standard connections
2.7
16.8
128
544
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.7
16.8
77
230
ZXA10
NOMESCO Finland
Bilateral
2.6
16.7
138
617
M79.6
ICD-10 Finland
Pain in limb
2.2
16.6
218
1233
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.9
16.5
55
121
127
Kela drug reimbursment
Transplant complication
8.5
16.5
36
45
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
11.7
16.4
30
27
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.8
16.4
73
213
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
7.6
16.3
38
53
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.6
16.2
131
578
CKC12
NOMESCO Finland
Photocoagulation of retina
6.4
16.2
43
72
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.3
16.2
176
909
N03AG01
ATC
valproic acid; systemic, rectal
4.0
15.9
65
176
H43.1
ICD-10 Finland
Vitreous haemorrhage
10.2
15.9
31
32
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
10.2
15.9
31
32
RS221
NOMESCO Finland
NA
7.0
15.8
39
59
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
13.4
15.8
27
21
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
15.7
138
638
F43.29
ICD-10 Finland
Adaptation disorder UNS
6.9
15.7
39
60
R5599
NOMESCO Finland
Other rehabilitation service
6.9
15.7
39
60
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
14.3
15.6
26
19
A02BC02
ATC
pantoprazole; systemic
2.1
15.5
320
2181
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.9
15.4
66
186
H02AB09
ATC
hydrocortisone; systemic
5.3
15.3
47
95
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.4
15.2
158
795
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
11.3
15.1
28
26
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
15.1
110
453
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
15.1
102
403
T90
ICPC
Diabetes non-insulin dependent
2.7
15.1
113
475
-69
ICPC
Other reason for encounter NEC
5.7
15.0
43
80
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.7
14.9
115
491
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
7.8
14.9
34
46
ZXA00
NOMESCO Finland
Right side
2.4
14.7
151
752
N05CF01
ATC
zopiclone; oral
2.3
14.7
157
798
UJF32
NOMESCO Finland
Coloscopy
2.4
14.5
137
651
F50.9
ICD-10 Finland
Eating disorder, unspecified
153.7
14.5
15
*
J01DB01
ATC
cefalexin; oral
2.3
14.5
476
3878
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.9
14.5
94
361
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
14.4
225
1354
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
13.9
14.3
24
18
R52.2
ICD-10 Finland
Other chronic pain
6.1
14.3
39
68
A10AE06
ATC
insulin degludec; parenteral
5.3
14.3
44
89
N06AX03
ATC
mianserin; oral
5.8
14.2
40
73
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
14.2
161
839
C08CA01
ATC
amlodipine; oral
2.4
14.1
145
720
A01
ICPC
Pain general/multiple sites
3.8
14.1
62
179
R11
ICD-10 Finland
Nausea and vomiting
3.1
14.0
81
288
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.5
14.0
36
58
R06.0
ICD-10 Finland
Dyspnoea
2.4
14.0
140
686
R4120
NOMESCO Finland
Occupational therapy
3.8
13.9
61
176
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
5.2
13.9
43
88
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
13.5
278
1852
N03AF02
ATC
oxcarbazepine; oral
5.4
13.4
40
78
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.8
13.4
58
165
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.1
13.4
77
273
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.9
13.4
56
155
A04AA01
ATC
ondansetron; systemic, rectal
3.7
13.3
60
177
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
11.3
13.1
24
22
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
4.7
13.0
44
99
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
5.0
13.0
42
90
A02BC01
ATC
omeprazole; systemic
2.2
13.0
156
832
R42
ICD-10 Finland
Dizziness and giddiness
2.5
13.0
112
508
F51.0
ICD-10 Finland
Nonorganic insomnia
2.9
13.0
85
327
N03AX11
ATC
topiramate; oral
5.7
12.9
37
69
Z94.0
ICD-10 Finland
Kidney transplant status
7.8
12.8
29
39
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
4.2
12.8
49
125
UKC02
NOMESCO Finland
Cystoscopy
2.9
12.8
84
324
J01MA02
ATC
ciprofloxacin; systemic
2.1
12.7
188
1096
TK800
NOMESCO Finland
Hemodialysis
8.5
12.7
27
33
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
4.2
12.6
48
122
ZX120
NOMESCO Finland
Intravenous
2.9
12.6
79
295
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
7.1
12.5
30
44
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
4.9
12.4
40
86
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
14.7
12.3
20
14
SPAT1262
SPAT
Handing over of treatment supplies
2.5
12.1
104
469
SAA03
NOMESCO Finland
Extended examination of mouth
1.9
12.1
300
2108
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.6
12.0
55
165
H02AB06
ATC
prednisolone; systemic
1.9
11.9
241
1573
A12AA04
ATC
calcium carbonate; oral
8.7
11.9
25
30
L04AA01
ATC
[U] ciclosporin; systemic
10.8
11.8
22
21
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
7.6
11.8
27
37
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
11.8
114
544
N02BE01
ATC
paracetamol; systemic, rectal
2.0
11.8
441
3573
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.4
11.8
59
189
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
6.2
11.8
31
52
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
6.0
11.8
32
56
A06AD11
ATC
lactulose; oral
2.9
11.8
73
272
WX002
NOMESCO Finland
Sedation and analgesia
2.3
11.8
116
560
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
16.8
11.7
18
11
Z71.8
ICD-10 Finland
Other specified counselling
2.1
11.7
168
961
XA820
NOMESCO Finland
NA
30.7
11.7
15
5
XA800
NOMESCO Finland
Neuropsychological investigation
3.4
11.7
58
185
R41.0
ICD-10 Finland
Disorientation, unspecified
8.4
11.7
25
31
P01
ICPC
Feeling anxious/nervous/tense
2.4
11.7
106
490
R20.2
ICD-10 Finland
Paraesthesia of skin
3.7
11.7
51
147
RS222
NOMESCO Finland
NA
7.4
11.6
27
38
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
11.6
94
410
N06AB06
ATC
sertraline; oral
2.7
11.6
85
350
R52.1
ICD-10 Finland
Chronic intractable pain
23.5
11.6
16
7
G50.1
ICD-10 Finland
Atypical facial pain
11.4
11.6
21
19
A28
ICPC
Limited function/disability NOS
2.7
11.6
82
332
-1
NOMESCO Finland
NA
1.9
11.6
264
1795
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.9
11.5
70
258
SPAT1216
SPAT
Assessment of functional ability
2.7
11.4
83
338
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
9.9
11.3
22
23
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
11.3
72
272
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.5
11.2
39
91
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
13.1
11.2
19
15
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
20.5
11.2
16
8
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
4.4
11.2
40
96
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
7.3
11.2
26
37
C07AB02
ATC
metoprolol; systemic
2.5
11.0
92
408
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.6
11.0
49
144
X59
ICD-10 Finland
Exposure to unspecified factor
2.2
10.9
121
614
R35
ICD-10 Finland
Polyuria
4.0
10.9
44
118
XF600
NOMESCO Finland
Bloodpressure measurement
2.9
10.9
70
265
Z49.1
ICD-10 Finland
Extracorporeal dialysis
9.1
10.9
22
25
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.9
10.8
44
119
X58
ICD-10 Finland
Exposure to other specified factors
2.4
10.8
103
487
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
10.8
126
656
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
7.8
10.8
24
32
H02AB04
ATC
methylprednisolone; systemic
2.5
10.7
86
373
G47.3
ICD-10 Finland
Sleep apnoea
2.4
10.7
101
477
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.5
10.7
49
147
ZXA05
NOMESCO Finland
Left side
2.1
10.6
131
701
K02.1
ICD-10 Finland
Caries of dentine
1.8
10.6
361
2773
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.7
10.5
35
78
E0000UV
ATC
NA
1.8
10.5
241
1624
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.5
10.5
49
149
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
5.5
10.4
30
57
A11CC03
ATC
alfacalcidol; systemic
5.5
10.4
30
57
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.3
10.4
108
534
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
3.1
10.4
59
207
J01MA12
ATC
levofloxacin; systemic
2.4
10.4
96
448
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.3
10.4
107
526
N06AA12
ATC
doxepin; systemic
4.8
10.4
34
75
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
3.5
10.4
49
151
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.6
10.3
78
328
R53
ICD-10 Finland
Malaise and fatigue
2.1
10.3
123
647
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
10.3
226
1499
XCK00
NOMESCO Finland
Perimetry
3.5
10.3
47
141
H3600, E103
ICD-10 Finland
NA
7.7
10.3
23
31
AA1AD
NOMESCO Finland
CT of head and brain
2.2
10.2
114
580
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.9
10.1
184
1140
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
10.1
328
2464
TPH07
NOMESCO Finland
Cathetrisation of artery
2.7
10.1
70
280
Z50.1
ICD-10 Finland
Other physical therapy
3.9
10.0
41
112
IGY99
NOMESCO Finland
Other psychiatric treatment contact
4.0
10.0
39
102
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.6
10.0
76
320
A02BA02
ATC
ranitidine; systemic
2.3
10.0
96
457
C07AB07
ATC
bisoprolol; oral
1.9
10.0
189
1190
A07AA02
ATC
nystatin; oral
3.8
9.9
41
113
RS211
NOMESCO Finland
NA
8.3
9.9
21
26
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
12.5
9.9
17
14
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.6
9.9
75
315
C09AA02
ATC
enalapril; systemic
2.5
9.9
83
368
G43.9
ICD-10 Finland
Migraine, unspecified
3.0
9.8
56
197
K59.1
ICD-10 Finland
Functional diarrhoea
3.8
9.8
41
114
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
5.5
9.8
28
53
G44.2
ICD-10 Finland
Tension-type headache
2.4
9.8
83
371
P25
ICPC
Phase of life problem adult
3.7
9.8
42
120
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.2
9.8
50
164
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.7
9.7
68
273
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.0
9.7
57
206
V03AE03
ATC
lanthanum carbonate; oral
56.0
9.7
11
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.0
9.6
140
798
H3601, E103
ICD-10 Finland
NA
9.3
9.6
19
21
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
6.8
9.5
23
35
-44
ICPC
Preventive immunization/medic
2.9
9.5
59
220
R55
ICD-10 Finland
Syncope and collapse
2.8
9.5
62
238
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
30.6
9.4
12
*
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
30.6
9.4
12
*
F45.9
ICD-10 Finland
Somatoform disorder, unspecified
30.6
9.4
12
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.8
9.4
39
108
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.7
9.4
31
69
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
9.4
58
215
A04
ICPC
Weakness/tiredness general
2.3
9.4
92
440
3004A
ICD-9 Finland
Neurotic disorders, Neurotic depression
22.1
9.4
13
6
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
6.6
9.3
23
36
A03FA02
ATC
cisapride; oral, rectal
3.3
9.3
46
147
S70.0
ICD-10 Finland
Contusion of hip
5.6
9.3
26
48
N01
ICPC
Headache
2.1
9.3
114
604
SPAT1229
SPAT
Assessment of need for aid
3.3
9.2
46
148
K07.60
ICD-10 Finland
Snapping jaw
3.3
9.2
46
148
137
Kela drug reimbursment
Uraemia requiring dialysis
7.9
9.2
20
26
A27
ICPC
Fear of other disease NOS
3.9
9.1
36
96
B01AB05
ATC
enoxaparin; parenteral
2.0
9.0
137
788
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.2
9.0
33
82
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.7
9.0
307
2302
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.3
8.9
89
428
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
8.9
219
1488
S18
ICPC
Laceration/cut
1.8
8.9
216
1461
K08.80
ICD-10 Finland
Toothache NOS
2.9
8.9
55
204
N30.0
ICD-10 Finland
Acute cystitis
2.2
8.9
91
445
G50.0
ICD-10 Finland
Trigeminal neuralgia
10.9
8.8
16
15
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.8
8.8
36
99
SPAT1252
SPAT
Overall medication plan or its review
3.6
8.8
39
115
J01EA01
ATC
trimethoprim; systemic
1.9
8.8
142
839
H04.10
ICD-10 Finland
Dry eye syndrome
2.8
8.8
58
224
B03XA02
ATC
darbepoetin alfa; parenteral
7.8
8.7
19
25
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.3
8.6
42
133
A02BC03
ATC
lansoprazole; oral
1.9
8.6
134
776
RS140
NOMESCO Finland
NA
11.8
8.6
15
13
A02BC05
ATC
esomeprazole; systemic
1.8
8.6
191
1256
R07.3
ICD-10 Finland
Other chest pain
2.8
8.6
54
204
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
8.6
64
267
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
8.6
85
411
C02AC05
ATC
moxonidine; oral
5.8
8.5
23
41
N05BA12
ATC
alprazolam; oral
2.7
8.5
58
230
N05CD07
ATC
temazepam; oral
2.8
8.5
53
198
WX882
NOMESCO Finland
High dependency care
3.1
8.5
45
152
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.0
8.5
26
54
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.6
8.5
37
108
N06AB05
ATC
paroxetine; oral
3.4
8.4
39
119
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.8
8.4
27
59
WX110
NOMESCO Finland
Local anesthesy
1.7
8.4
414
3425
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
8.4
102
537
F34.1
ICD-10 Finland
Dysthymia
3.9
8.4
33
88
P76
ICPC
Depressive disorder
2.9
8.4
49
177
B05DA
ATC
Isotonic solutions
8.7
8.4
17
20
K06.18
ICD-10 Finland
Another gingival hyperplasia
11.0
8.3
15
14
Z49.2
ICD-10 Finland
Other dialysis
9.6
8.3
16
17
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.9
8.3
50
184
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
8.3
281
2087
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.8
8.2
51
190
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.7
8.2
58
233
81
HP
Angiography of the heart and coronary arteries
5.0
8.2
25
52
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
8.1
108
590
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
33.9
8.1
10
*
CL2L4
NOMESCO Finland
Wide-field fundus photography for diabetic retinopathy screening
33.9
8.1
10
*
W19
ICD-10 Finland
Unspecified fall
2.5
8.1
65
283
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.3
8.1
81
390
N18.0
ICD-10 Finland
End-stage renal disease
10.2
8.1
15
15
A10AA03
ATC
NA
10.2
8.1
15
15
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
6.0
8.1
21
36
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
22.4
8.0
11
5
N05AF03
ATC
chlorprothixene; systemic
4.9
8.0
25
53
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.5
8.0
64
277
F43.1
ICD-10 Finland
Post-traumatic stress disorder
4.2
8.0
29
72
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.5
8.0
63
270
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
6.7
7.9
19
29
N05BA09
ATC
clobazam; oral
7.9
7.9
17
22
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
6.2
7.9
20
33
N05CF02
ATC
zolpidem; oral
2.2
7.8
86
431
H36.00
ICD-10 Finland
Diabetic background retinopathy
11.0
7.8
14
13
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
5.2
7.8
23
46
N03AX14
ATC
levetiracetam; systemic
4.2
7.8
28
69
N06AA06
ATC
trimipramine; systemic
5.4
7.8
22
42
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.9
7.7
45
162
M54.6
ICD-10 Finland
Pain in thoracic spine
3.0
7.7
42
145
KMAK
NOMESCO Finland
NA
1.6
7.7
274
2047
L04AX01
ATC
azathioprine; systemic
3.1
7.7
41
140
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
5.1
7.7
23
47
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.1
7.7
95
504
P29
ICPC
Psychological sympt/compl other
2.6
7.6
56
232
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.4
7.6
26
61
G04BD04
ATC
oxybutynin; oral, transdermal
3.7
7.6
32
91
F41.00
ICD-10 Finland
Moderate panic disorder
5.9
7.6
20
35
F39
ICD-10 Finland
Unspecified mood [affective] disorder
5.9
7.6
20
35
B05DB
ATC
Hypertonic solutions
9.0
7.6
15
17
QBA10
NOMESCO Finland
Incision of skin of trunk
9.0
7.6
15
17
TKC20
NOMESCO Finland
Catheterisation of bladder
3.2
7.6
38
124
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.8
7.6
48
182
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
10.2
7.6
14
14
SAA01
NOMESCO Finland
Simple examination of mouth
1.7
7.6
426
3596
L04AD01
ATC
ciclosporin; systemic
4.5
7.5
25
57
S10
ICPC
Boil/carbuncle
3.4
7.5
35
108
A41.9
ICD-10 Finland
Sepsis, unspecified
3.7
7.5
31
87
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
3.7
7.5
31
87
NG4AA
NOMESCO Finland
Lower leg X-ray examination
4.0
7.5
28
72
XKC03
NOMESCO Finland
Water cystometry
4.7
7.5
24
53
F43.8
ICD-10 Finland
Other reactions to severe stress
4.7
7.5
24
53
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
7.5
112
641
TLC00
NOMESCO Finland
Insertion of intrauterine device
2.7
7.4
48
185
WW200
NOMESCO Finland
Immunization
4.5
7.4
25
58
205
Kela drug reimbursment
Chronic hypertension
2.0
7.4
97
525
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.7
7.4
50
195
N18.8
ICD-10 Finland
Other chronic renal failure
4.8
7.4
23
49
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.7
7.4
48
186
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.1
7.4
27
68
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.2
7.3
72
345
M01AH01
ATC
celecoxib; oral (coxibs)
2.2
7.3
77
382
TAB00
NOMESCO Finland
Lumbar puncture
3.2
7.3
36
116
K65.0
ICD-10 Finland
Acute peritonitis
9.5
7.3
14
15
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.6
7.3
31
89
F43.9
ICD-10 Finland
Reaction to severe stress, unspecified
4.2
7.3
26
64
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.9
7.3
43
157
R33
ICD-10 Finland
Retention of urine
3.1
7.3
38
128
E000003
ATC
NA
3.1
7.3
38
128
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
7.2
105
592
EBA00
NOMESCO Finland
Extraction of tooth
1.7
7.2
213
1505
M25.5
ICD-10 Finland
Pain in joint
1.8
7.2
154
990
N05BE01
ATC
buspirone; oral
4.9
7.2
22
46
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
3.6
7.2
31
90
WX892
NOMESCO Finland
Monitored bed care
2.8
7.2
46
176
C10AA01
ATC
simvastatin; oral
1.8
7.2
140
875
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.0
7.2
27
70
C09CA06
ATC
candesartan; oral
2.0
7.2
97
532
R52.9
ICD-10 Finland
Pain, unspecified
2.5
7.2
53
221
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.4
7.2
61
273
J01MA14
ATC
moxifloxacin; systemic
2.8
7.2
45
169
196
Kela drug reimbursment
Paricalcitol and cinacalcet
20.3
7.2
10
5
M54.2
ICD-10 Finland
Cervicalgia
2.9
7.1
41
146
C07AA05
ATC
propranolol; systemic
1.9
7.1
111
643
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.7
7.1
46
178
U14
ICPC
Kidney symptom/complaint
10.2
7.1
13
13
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.5
7.0
57
247
D07CA01
ATC
hydrocortisone and antibiotics; topical
2.1
7.0
83
433
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.4
7.0
58
257
H01AC01
ATC
somatropin; parenteral
5.3
7.0
20
39
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.2
7.0
70
340
R03AC02
ATC
salbutamol; inhalant
1.6
7.0
306
2394
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
4.7
7.0
22
48
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
7.7
6.9
15
20
WZA90
NOMESCO Finland
Other doctors statement
1.7
6.9
160
1054
J01DA01
ATC
[U] cefalexin; systemic
1.6
6.9
301
2348
SPAT1234
SPAT
Support of social functional capacity
3.6
6.9
29
83
J02AC01
ATC
fluconazole; systemic
1.6
6.9
207
1464
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
6.9
169
1132
P74
ICPC
Anxiety disorder/anxiety state
3.1
6.9
36
122
K59.0
ICD-10 Finland
Constipation
3.0
6.8
39
138
F61.0
ICD-10 Finland
Mixed personality disorders
5.4
6.8
19
36
M03BX01
ATC
baclofen; systemic
5.4
6.8
19
36
L17
ICPC
Foot/toe symptom/complaint
1.7
6.8
146
938
F32.8
ICD-10 Finland
Other depressive episodes
6.2
6.8
17
28
CKC15
NOMESCO Finland
Panretinal photocoagulation
9.5
6.8
13
14
M79.7
ICD-10 Finland
Fibromyalgia
4.4
6.8
23
54
J11.1
ICD-10 Finland
Influenza with other respiratory manifestations, virus not identified
4.8
6.8
21
45
F50.8
ICD-10 Finland
Other eating disorders
40.5
6.8
8
*
H57.1
ICD-10 Finland
Ocular pain
4.0
6.8
25
64
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.2
6.8
34
112
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
6.7
419
3566
A29
ICPC
General symptom/complaint other
2.2
6.7
68
331
M54.5
ICD-10 Finland
Low back pain
1.7
6.7
162
1080
QDA10
NOMESCO Finland
Incision of skin of lower limb
22.8
6.7
9
*
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.2
6.7
70
346
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
4.3
6.7
23
55
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
4.3
6.7
23
55
I20.90
ICD-10 Finland
Angina pectoris, unspecified
5.3
6.7
19
37
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.7
6.7
27
75
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
4.1
6.7
24
60
RF210
NOMESCO Finland
NA
4.0
6.7
25
65
N06AX12
ATC
bupropion; oral
2.7
6.6
44
173
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
2.3
6.6
60
275
V03AE02
ATC
sevelamer; oral
12.4
6.6
11
9
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
6.6
194
1361
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
8.8
6.6
13
15
S80.0
ICD-10 Finland
Contusion of knee
2.5
6.6
49
205
RS120
NOMESCO Finland
NA
10.2
6.6
12
12
J01AA02
ATC
doxycycline; systemic
1.6
6.5
347
2826
C10AA05
ATC
atorvastatin; oral
1.8
6.5
127
792
A46
ICD-10 Finland
Erysipelas
2.3
6.5
60
281
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.3
6.5
59
271
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.1
6.5
71
358
K59.09
ICD-10 Finland
Constipation, unspecified
2.7
6.5
42
163
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
3.9
6.5
25
67
T78.4
ICD-10 Finland
Allergy, unspecified
2.9
6.5
38
139
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
7.5
6.4
14
19
F50.0
ICD-10 Finland
Anorexia nervosa
70.6
6.4
7
*
E10.0
ICD-10 Finland
Type 1 diabetes mellitus, With coma
70.6
6.4
7
*
RJ210
NOMESCO Finland
NA
70.6
6.4
7
*
RS123
NOMESCO Finland
NA
70.6
6.4
7
*
H36.02
ICD-10 Finland
Preproliferative diabetic retinopathy
70.6
6.4
7
*
JLE03
NOMESCO Finland
Allogenic total transplantation of pancreas with pancreaticoenterostomy
70.6
6.4
7
*
M03BX02
ATC
tizanidine; oral
1.6
6.4
283
2200
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
3.6
6.4
27
78
M01AH02
ATC
rofecoxib; oral
2.3
6.4
57
263
V03AE01
ATC
polystyrene sulfonate; oral
8.3
6.4
13
16
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
8.3
6.4
13
16
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.5
6.3
50
214
K10.3
ICD-10 Finland
Alveolitis of jaws
3.0
6.3
34
118
Z99.2
ICD-10 Finland
Dependence on renal dialysis
18.3
6.3
9
5
U05
ICPC
Urination problems other
3.6
6.3
26
74
N05AH03
ATC
olanzapine; systemic
2.8
6.3
37
136
C09AA05
ATC
ramipril; oral
2.0
6.3
83
452
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
7.1
6.2
14
20
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
27.0
6.2
8
*
RJ120
NOMESCO Finland
NA
27.0
6.2
8
*
Z70.8
ICD-10 Finland
Other sex counselling
27.0
6.2
8
*
S29
ICPC
Skin symptom/complaint other
1.9
6.2
97
560
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
3.5
6.2
27
80
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.0
6.2
83
455
M50.3
ICD-10 Finland
Other cervical disc degeneration
5.4
6.2
17
32
R02
ICPC
Shortness of breath/dyspnoea
2.2
6.2
62
300
A07EA06
ATC
budesonide; oral, local oral
3.6
6.2
26
75
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
6.2
177
1230
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
7.8
6.1
13
17
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.3
6.1
29
92
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.7
6.1
134
864
SPAT1240
SPAT
Therapeutic discussion
2.0
6.1
78
418
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
3.5
6.1
26
76
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.1
6.1
68
346
P06
ICPC
Sleep disturbance
2.3
6.1
54
247
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.3
6.1
52
235
N06AX22
ATC
agomelatine; oral
4.2
6.1
21
51
Z00.0
ICD-10 Finland
General medical examination
1.8
6.1
109
661
M89.0
ICD-10 Finland
Algoneurodystrophy
10.2
6.1
11
11
N03AB02
ATC
phenytoin; systemic
10.2
6.1
11
11
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
3.9
6.0
23
61
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
6.1
6.0
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
362
2011
2.86
36.81
3.7
2.6
nmol/l
72.4
73.4
0.30
338
1834
(3000850) Epithelial cells [#/volume] in Urine
232
1021
3.00
36.53
4.4
2.6
e6/l
6.3
7.4
0.40
213
893
(36304419) Bacteria [Presence] in Urine
276
1339
2.87
36.23
5.7
3.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
387
2254
2.83
35.46
14.7
7.5
mmol/l
1.2
1.2
0.66
353
1933
(3009508) Creatinine [Moles/volume] in Urine
280
1388
2.82
35.01
6.1
3.3
mmol/l
7.1
8.1
3.61
248
1198
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
364
2080
2.75
34.19
13.4
7.1
mmol/l
1.2
1.2
0.98
345
1915
(3030467) Casts [#/volume] in Urine by Automated count
273
1349
2.79
34.17
6.0
3.2
e6/l
0.3
0.4
0.63
232
1009
(3012516) Albumin [Mass/volume] in Urine
234
1069
2.88
33.99
5.0
3.3
mg/l
778.4
119.9
1.04
178
713
(3020682) Albumin/Creatinine [Ratio] in Urine
237
1111
2.81
32.53
5.8
4.1
mg/mmol
23.1
10.1
1.55
176
729
(3002582) Erythrocytes [#/volume] in Urine
284
1475
2.67
31.65
6.2
3.3
e6/l
23.1
47.2
1.67
242
1130
(3012095) Magnesium [Moles/volume] in Serum or Plasma
171
697
2.99
30.15
6.2
5.7
mmol/l
0.8
0.8
0.84
160
662
(40758558) Short blood count panel - Blood
269
1386
2.63
30.14
13.4
7.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
159
639
2.98
28.61
2.2
1.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
137
518
3.10
27.35
12.4
9.6
—
—
—
0
0
(3026782) Osmolality of Urine
205
962
2.67
27.31
4.4
2.8
mosm/kgh2o
524.2
587.1
3.16
188
827
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
297
1672
2.46
26.78
6.1
3.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
124
460
3.11
25.46
2.2
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
304
1760
2.39
25.37
7.2
3.7
e6/l
157.0
73.2
0.61
245
1205
(3018418) pH of Serum or Plasma
240
1258
2.46
24.95
9.2
3.8
ph
7.4
7.4
1.86
37
240
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
74
206
3.93
23.67
1.9
1.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
138
566
2.84
23.53
12.5
6.3
mmol/l
1.1
1.6
0.85
118
451
(3033658) Prothrombin time (PT) actual/Normal
235
1247
2.40
23.50
7.7
4.7
%
92.6
91.2
0.39
229
1220
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
121
465
2.98
23.22
2.2
1.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
205
1028
2.47
23.20
6.4
4.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
156
688
2.68
23.07
4.1
2.5
umol/l
12.8
13.8
1.08
143
641
(3004789) Transferrin [Mass/volume] in Serum or Plasma
146
626
2.73
22.80
4.3
2.5
g/l
2.3
2.4
1.61
133
580
(42870588) Differential panel, method unspecified - Blood
301
1814
2.25
21.95
11.6
6.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
405
2793
2.24
20.67
8.7
4.8
mmol/l
7.2
6.4
4.28
388
2553
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
98
356
3.07
20.65
8.5
5.5
ng/l
113.1
70.7
1.61
90
331
(3026250) Tacrolimus [Mass/volume] in Blood
27
33
8.50
20.64
43.8
37.2
ug/l
7.2
6.3
1.27
27
27
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
133
578
2.65
20.02
4.6
2.6
%
21.8
23.2
0.66
115
507
(3013650) Neutrophils [#/volume] in Blood by Automated count
430
3069
2.24
19.72
15.8
9.2
e9/l
4.1
3.9
1.20
387
2656
(3022096) Basophils/100 leukocytes in Blood
367
2472
2.15
19.37
12.3
6.7
%
0.6
0.7
1.22
355
2326
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
158
761
2.43
19.06
4.9
3.0
e6/l
4.1
2.5
1.00
95
409
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
162
795
2.39
18.71
4.9
2.9
e6/l
1.1
0.7
0.75
102
440
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
89
327
3.00
18.30
5.2
2.6
ml/min/173m2
54.2
73.5
3.12
31
136
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
262
1579
2.12
18.22
2.0
1.8
pmol/l
95.7
97.0
0.14
131
812
(3006315) Basophils [#/volume] in Blood
387
2706
2.10
17.94
11.9
6.5
e9/l
0.0
0.0
0.73
346
2331
(3001604) Monocytes [#/volume] in Blood
386
2699
2.09
17.86
11.9
6.5
e9/l
0.6
0.5
1.80
344
2329
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
344
2310
2.07
17.72
8.8
6.3
umol/l
10.5
10.6
0.09
327
2170
(3006504) Eosinophils/100 leukocytes in Blood
370
2554
2.07
17.64
12.2
6.6
%
2.9
2.9
0.09
359
2396
(3019069) Monocytes/100 leukocytes in Blood
371
2570
2.06
17.44
12.5
6.8
%
8.4
8.3
0.29
360
2428
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
110
466
2.65
17.27
6.7
5.6
mmol/l
1.5
1.4
0.15
82
345
(3014576) Chloride [Moles/volume] in Serum or Plasma
112
484
2.59
16.87
11.2
6.9
mmol/l
104.5
104.3
0.16
112
475
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
19
19
10.28
16.77
6.5
7.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
45
112
4.25
16.67
8.6
8.7
iu/ml
1954.6
410.3
—
7
16
(3009343) pH of Capillary blood
110
477
2.58
16.43
6.8
5.5
ph
7.4
7.4
—
7
37
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
42
101
4.38
16.26
1.7
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
42
101
4.38
16.26
1.7
1.3
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
373
2630
2.01
16.20
12.2
6.4
%
55.5
54.7
0.67
360
2488
(3019198) Lymphocytes [#/volume] in Blood
389
2788
2.02
16.08
12.0
6.5
e9/l
1.9
2.0
0.90
353
2454
(3021960) Folate [Moles/volume] in Serum or Plasma
168
890
2.21
15.90
1.5
1.4
nmol/l
20.4
20.0
0.13
143
763
(3024561) Albumin [Mass/volume] in Serum or Plasma
280
1797
2.00
15.82
9.9
5.3
g/l
34.9
36.7
5.18
260
1693
(3002030) Lymphocytes/100 leukocytes in Blood
374
2658
1.99
15.67
12.4
6.6
%
29.3
30.7
1.78
362
2512
(3023103) Potassium [Moles/volume] in Serum or Plasma
596
5113
3.63
15.66
28.2
12.5
mmol/l
3.9
3.9
0.55
589
4934
(3013115) Eosinophils [#/volume] in Blood
389
2803
2.00
15.65
12.9
6.9
e9/l
0.2
0.2
0.05
353
2455
(3019550) Sodium [Moles/volume] in Serum or Plasma
595
5103
3.57
15.56
27.7
12.4
mmol/l
139.1
139.6
6.47
588
4944
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
204
1182
2.07
15.21
3.0
2.1
u/l
150.8
270.7
1.27
194
1124
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
187
1054
2.10
14.98
2.7
2.3
mg/l
2.2
1.0
0.78
134
791
(3011397) Hemoglobin [Presence] in Urine by Test strip
196
1125
2.07
14.95
4.4
3.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
461
3573
2.05
14.53
11.1
6.6
u/l
89.8
86.5
0.53
443
3337
(3036481) Cortisol [Moles/volume] in Serum or Plasma
113
524
2.41
14.53
2.8
2.2
nmol/l
316.7
367.4
2.00
106
489
(3045414) Leukocytes [Presence] in Urine
59
196
3.22
14.34
2.3
1.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
39
98
4.17
14.27
2.7
1.9
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
101
449
2.49
14.22
4.9
2.2
u/l
44.8
32.9
0.66
78
377
(3052851) Hemolysis interference index of Serum or Plasma
48
143
3.55
13.84
4.5
3.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
123
608
2.27
13.59
3.4
1.9
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
47
140
3.55
13.55
3.1
2.2
g/l
1.3
1.4
0.14
40
123
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
89
386
2.52
13.17
7.1
5.7
mmol/l
24.2
24.5
0.54
89
378
(3003396) Base excess in Arterial blood by calculation
92
406
2.48
13.12
7.5
9.4
mmol/l
0.3
0.9
0.61
77
332
(3037467) Urinalysis macro (dipstick) panel - Urine
444
3456
1.94
13.02
7.1
3.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
253
1652
1.88
12.90
5.3
3.7
u/l
31.0
31.0
0.01
240
1581
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
524
4347
2.17
12.53
20.2
9.9
ml/min/173m2
90.0
89.9
0.02
452
3397
(3021589) Normoblasts [#/volume] in Blood
345
2502
1.83
12.39
15.8
9.1
e9/l
0.0
0.0
0.11
287
1993
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
503
4119
2.06
12.32
7.2
4.9
mmol/mol
44.5
38.7
13.50
470
3868
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
71
285
2.68
12.27
2.7
1.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
117
591
2.20
12.19
5.4
4.4
umol/l
5.3
7.5
1.20
102
502
(3042733) HLA Ab [Presence] in Serum
15
17
9.01
12.04
4.0
3.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
34
90
3.93
11.61
13.6
5.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
494
4059
1.97
11.42
5.0
3.9
pmol/l
14.2
14.5
2.17
463
3721
(3019309) Folate [Moles/volume] in Red Blood Cells
120
633
2.10
11.13
1.8
1.6
nmol/l
1131.3
1169.0
0.16
97
479
(3032080) INR in Blood by Coagulation assay
241
1607
1.80
11.10
9.9
7.0
inr
1.2
1.2
0.26
96
519
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
36
103
3.64
11.02
1.6
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
214
1380
1.83
10.98
5.6
2.5
u/l
75.3
56.7
0.42
204
1277
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
190
1187
1.86
10.76
3.3
2.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
114
599
2.10
10.66
1.3
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
25
56
4.61
10.57
3.6
2.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
194
1226
1.84
10.56
3.3
2.5
mg/l
2.9
2.8
0.10
170
1057
(3026008) Bacteria identified in Urine by Culture
210
1365
1.80
10.40
4.4
2.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
192
1218
1.83
10.28
2.0
1.7
mmol/l
1.3
1.4
0.42
172
1051
(3044640) Blood type and Crossmatch panel - Blood
227
1524
1.76
9.99
3.7
2.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
36
113
3.32
9.59
4.5
2.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
58
239
2.57
9.50
1.5
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
233
1594
1.73
9.49
2.1
1.4
u/ml
2.1
2.3
0.07
34
370
(3022313) Gas panel - Capillary blood
80
390
2.20
9.00
7.6
5.9
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
34
109
3.24
8.77
9.4
1.9
nmol/l
0.9
0.7
0.30
29
93
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
546
4778
2.01
8.70
5.8
4.4
mu/l
1.8
2.1
0.69
512
4431
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
14
22
6.48
8.56
6.0
7.7
mg/l
3.2
1.8
1.25
14
17
(3007853) Bacteria identified in Skin by Aerobe culture
105
578
1.98
8.55
2.6
1.6
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
27
76
3.67
8.48
15.7
6.8
%
68.9
64.9
0.46
27
76
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
131
780
1.86
8.42
3.9
3.3
ng/l
126.1
546.9
1.92
94
516
(40768446) Kidney Pathology biopsy report
15
26
5.88
8.36
2.6
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
108
605
1.95
8.35
1.3
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
95
517
1.98
7.97
5.9
4.0
%
1.6
1.6
0.18
86
480
(3002385) Erythrocyte distribution width [Ratio]
537
4724
1.88
7.69
32.3
14.2
%
13.5
13.4
0.49
529
4644
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
39
149
2.72
7.43
2.1
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
77
399
2.06
7.39
16.5
17.4
inr
1.3
1.3
—
6
64
(3020630) Protein [Mass/volume] in Serum or Plasma
58
269
2.27
7.35
5.3
2.6
g/l
63.2
66.8
1.84
53
246
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
48
207
2.43
7.17
9.3
12.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
320
2503
1.56
7.01
4.7
2.9
ug/l
83.4
81.9
0.07
305
2344
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
14
27
5.28
7.00
2.0
2.0
u/ml
557.1
713.8
0.37
14
27
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
42
172
2.54
6.99
2.0
1.6
u/ml
219.7
210.7
0.07
31
88
(3005719) IgG [Mass/volume] in Serum or Plasma
80
430
1.98
6.94
5.4
2.8
g/l
10.0
9.8
0.15
74
402
(3044889) 12 lead EKG panel
378
3075
1.57
6.91
3.7
3.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
580
5280
2.12
6.88
26.1
11.2
mg/l
22.1
21.0
0.35
471
3958
(3007164) IgA [Mass/volume] in Serum or Plasma
204
1444
1.61
6.84
2.0
1.5
g/l
2.0
2.0
0.05
102
834
(1761868) Lipid panel - Serum or Plasma
116
1768
0.58
6.55
2.9
2.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
42
179
2.44
6.45
1.5
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
34
131
2.69
6.40
4.7
2.6
e6/l
1.3
10.1
1.08
25
106
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
34
131
2.69
6.40
4.7
2.6
e6/l
41.5
983.9
0.62
27
110
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
15
6.76
6.33
1.8
3.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
120
754
1.73
6.33
2.1
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
12
22
5.54
6.31
1.0
1.0
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
18
47
3.91
6.30
6.9
4.2
e6/l
147.3
217.5
0.60
11
28
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
41
175
2.44
6.28
2.0
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
45
201
2.33
6.24
4.5
2.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
63
324
2.05
6.17
4.1
3.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
44
196
2.34
6.14
3.7
3.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
308
2435
1.51
6.13
4.9
3.3
estimate
0.0
0.0
0.00
69
487
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
31
4.60
6.01
1.1
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
16
6.33
5.97
1.0
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
41
180
2.37
5.91
3.2
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
295
2324
1.50
5.90
4.7
4.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
18
50
3.68
5.79
1.6
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
19
55
3.53
5.77
2.1
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
16
41
3.98
5.74
5.6
4.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
587
5428
2.06
5.70
16.1
9.2
u/l
26.1
26.0
0.02
571
5234
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
111
2.69
5.55
4.9
1.6
g/l
2.8
3.1
1.02
21
90
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
111
2.69
5.55
4.9
1.6
g/l
10.7
10.0
0.17
21
97
(3021601) Nitrite [Presence] in Urine by Test strip
305
2440
1.48
5.54
7.0
4.5
estimate
0.0
0.0
0.50
68
503
(3015377) Calcium [Moles/volume] in Serum or Plasma
198
1453
1.53
5.46
4.5
3.0
mmol/l
2.4
2.4
0.17
174
1285
(1616796) Gas panel - Central venous blood
26
95
2.81
5.43
3.6
4.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
122
801
1.65
5.41
1.7
1.6
pmol/l
429.4
9724671.0
0.50
105
689
(3000494) Fungus identified in Specimen by Culture
91
552
1.76
5.40
1.8
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
54
276
2.05
5.39
3.3
2.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
34
4.19
5.38
1.1
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
25
90
2.85
5.36
2.1
1.9
g/l
0.6
0.7
0.39
20
77
(3009214) Lutropin [Units/volume] in Serum or Plasma
54
277
2.04
5.34
2.3
1.9
u/l
6.2
8.3
0.79
39
195
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
18
5.63
5.33
1.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
592
5511
2.07
5.32
20.5
10.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
11
22
5.07
5.28
1.0
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
41
190
2.24
5.25
9.7
5.0
g/l
0.6
0.2
1.27
30
106
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
34
145
2.42
5.24
1.9
2.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
26
97
2.75
5.23
1.6
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
67
374
1.88
5.21
4.3
3.3
e9/l
66.0
69.0
0.30
52
276
(3037522) Nuclear Ab [Titer] in Serum
110
713
1.66
5.12
1.6
1.4
titre
316.2
541.3
1.40
21
152
(3009261) Glucose [Presence] in Urine by Test strip
306
2479
1.45
5.06
5.2
3.3
estimate
0.0
0.0
0.50
65
487
(3013707) Erythrocyte sedimentation rate by Westergren method
425
3668
1.48
5.01
6.4
4.0
mm/h
12.2
9.7
3.14
401
3386
(3000570) Elastase.pancreatic [Mass/mass] in Stool
30
124
2.49
4.95
1.4
1.4
ug/g
216.4
301.4
1.29
17
64
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
118
2.53
4.94
4.9
1.6
g/l
7.1
7.3
0.25
21
94
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
118
2.53
4.94
4.9
1.6
g/l
3.3
3.8
0.75
21
89
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
118
2.53
4.94
4.9
1.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
63
351
1.88
4.93
2.6
1.8
g/l
1.7
1.2
0.68
57
329
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
21
72
2.98
4.91
1.7
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
17
51
3.40
4.91
5.4
4.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
29
119
2.51
4.86
1.4
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
56
302
1.94
4.83
1.9
1.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
21
73
2.94
4.80
1.1
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
24
90
2.73
4.80
3.1
2.4
ug/min
107.3
76.6
0.27
18
48
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
26
102
2.62
4.77
5.8
1.8
g/l
2.1
0.5
0.43
20
92
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
22
79
2.85
4.76
2.2
2.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
21
74
2.90
4.70
6.9
3.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
199
1503
1.47
4.66
5.1
3.1
ng/l
139.8
34.3
0.65
142
849
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
25
99
2.59
4.51
5.5
1.7
g/l
36.3
39.3
1.28
20
87
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
12
30
4.06
4.45
1.1
1.1
%
79.2
82.8
0.11
12
30
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
12
30
4.06
4.45
1.1
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
139
984
1.53
4.43
3.8
3.3
ng/l
882.0
943.5
0.09
120
824
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
51
275
1.93
4.42
2.4
3.0
ng/l
118.4
161.5
0.54
45
254
(3048929) Epstein Barr virus Ab [Presence] in Serum
58
328
1.85
4.35
1.8
1.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
18
61
3.01
4.31
3.2
3.1
e6/l
931.8
796.6
—
5
18
(40768804) Tissue Pathology biopsy report
233
1839
1.42
4.24
2.2
2.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
14
41
3.47
4.20
3.3
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
145
1048
1.50
4.17
5.4
2.9
umol/l
323.1
5394.8
3.59
128
923
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
17
57
3.04
4.15
1.2
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
27
116
2.39
4.14
4.6
6.2
u/ml
0.3
0.3
0.10
18
66
(3023323) Follitropin [Units/volume] in Serum or Plasma
61
357
1.78
4.10
2.2
1.7
iu/l
15.2
18.8
0.47
46
274
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
23
93
2.53
4.01
2.0
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
20
76
2.68
3.93
5.7
3.5
e9/l
1.4
1.2
0.44
12
42
(4062490)
17
59
2.93
3.92
1.9
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
24
4.22
3.90
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
24
4.22
3.90
1.1
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
20
77
2.65
3.84
1.2
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
14
44
3.23
3.79
24.4
7.7
%
11.9
11.5
0.14
14
44
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
17
61
2.84
3.71
1.6
1.9
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
30
3.71
3.65
1.0
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
509
4656
1.47
3.64
5.2
4.2
mmol/l
2.6
2.8
4.06
475
4336
(3021879) Hepatitis B virus core Ab [Presence] in Serum
72
457
1.65
3.64
1.5
1.4
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
12
35
3.48
3.63
1.3
1.6
umol/l
10.2
9.6
0.19
12
35
(4035726)
59
355
1.73
3.63
1.5
1.4
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
10
26
3.89
3.53
2.2
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
245
0.32
3.51
1.4
1.5
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
6
6
10.08
3.50
1.0
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
57
344
1.72
3.47
3.0
2.1
nmol/l
10.2
11.6
0.39
38
301
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
35
181
1.99
3.45
13.2
3.8
%
0.5
0.7
1.55
35
175
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
189
0.26
3.29
1.4
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
54
2.82
3.27
1.5
1.3
nmol/l
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
15
54
2.82
3.27
8.9
4.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
379
3329
1.34
3.25
4.6
3.4
u/l
42.1
40.1
0.25
360
3155
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
26
123
2.16
3.24
1.5
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
19
78
2.48
3.24
1.5
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
54
328
1.71
3.23
5.2
4.8
mmol/l
1.2
1.2
0.14
49
286
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
95
667
1.50
3.12
1.8
1.7
%
1.6
1.4
1.13
76
600
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
16
62
2.62
3.06
6.6
3.9
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
23
106
2.21
3.06
2.0
2.4
g/l
131.6
132.5
0.05
17
83
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
55
341
1.67
3.06
3.7
3.4
pmol/l
4.4
4.8
2.63
50
309
(3048689) Calprotectin [Mass/mass] in Stool
115
842
1.45
3.06
3.3
2.8
ug/g
111.9
101.2
0.20
94
666
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
498
4582
1.40
3.06
4.8
3.8
mmol/l
1.4
1.5
2.35
467
4278
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
8
16
5.05
3.06
5.5
6.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
8
16
5.05
3.06
4.4
5.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
500
4605
1.40
3.04
4.9
3.9
mmol/l
4.5
4.7
4.64
470
4319
(3045424) Erythrocytes [Presence] in Urine
18
75
2.44
2.99
1.5
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
24
114
2.15
2.98
1.9
2.6
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
19
82
2.36
2.94
6.3
5.1
umol/l
418.5
379.4
0.88
19
77
(4198724)
13
46
2.86
2.93
1.2
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
16
64
2.54
2.89
1.4
1.5
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
9
6.72
2.87
3.0
2.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
23
110
2.13
2.82
1.2
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
28
508
0.53
2.81
1.4
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
73
496
1.53
2.80
1.5
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
25
124
2.06
2.80
2.6
1.7
ug/l
0.6
3.7
0.82
20
113
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
10
31
3.26
2.78
2.3
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
22
104
2.16
2.77
2.3
2.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
33
568
0.56
2.77
1.2
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
52
327
1.64
2.76
1.2
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
14
5.04
2.73
3.1
2.3
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
7
14
5.04
2.73
1.3
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
29
516
0.54
2.73
1.5
1.5
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
14
54
2.63
2.72
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
14
54
2.63
2.72
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
14
54
2.63
2.72
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
14
54
2.63
2.72
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
14
54
2.63
2.72
1.1
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
18
79
2.32
2.70
8.9
3.6
—
3.1
—
0
8
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
35
198
1.81
2.69
1.6
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
479
4411
1.35
2.68
4.4
3.5
mmol/l
1.3
1.2
0.93
446
4107
(3016879) Cocaine [Presence] in Urine
53
338
1.62
2.67
2.9
1.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
17
358
0.46
2.66
1.4
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
32
177
1.85
2.65
1.5
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
14
55
2.58
2.63
1.1
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
48
300
1.65
2.62
1.4
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
19
87
2.22
2.59
1.1
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
18
81
2.26
2.56
8.9
3.8
mg/l
19.6
28.6
0.97
13
66
(3034860) Kappa light chains.free [Mass/volume] in Serum
18
81
2.26
2.56
8.9
3.8
mg/l
62.1
55.0
0.08
13
66
(3051593) INR in Capillary blood by Coagulation assay
6
11
5.50
2.55
18.3
7.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
42
256
1.69
2.52
5.6
2.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
18
82
2.23
2.49
1.2
1.2
u/ml
5.7
3.7
—
6
33
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
26
3.50
2.49
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
9
26
3.50
2.49
3.8
3.0
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
7
16
4.41
2.48
3.4
3.1
umol/l
1.1
1.1
—
7
16
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
16
4.41
2.48
3.0
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
63
2.41
2.48
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
46
289
1.64
2.47
3.1
1.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
36
212
1.74
2.45
4.9
6.6
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
12
5.04
2.40
1.2
5.4
—
—
—
0
0
(4010399)
49
318
1.59
2.32
1.5
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
67
467
1.49
2.31
1.1
1.3
iu/ml
40.1
157.6
—
9
190
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
12
47
2.58
2.28
1.1
1.1
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
8
23
3.51
2.27
1.6
1.8
nmol/l
2.9
9.7
—
8
18
(3021901) Oxygen saturation in Capillary blood
17
79
2.18
2.26
3.4
3.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
18
3.92
2.25
2.3
3.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
18
3.92
2.25
2.3
3.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
18
3.92
2.25
1.1
1.4
nmol/l
138.7
128.6
—
7
18
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
60
411
1.51
2.25
4.6
2.9
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
14
60
2.36
2.23
1.1
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
73
2.22
2.22
1.4
1.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
11
42
2.65
2.19
3.6
4.1
umol/l
26.8
28.6
0.24
11
42
(4306422)
15
67
2.27
2.19
1.0
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
31
182
1.74
2.15
1.4
2.0
u/l
36.2
39.2
0.36
25
167
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
52
349
1.53
2.15
4.1
3.8
ug/l
2.6
40.7
0.97
44
279
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
15
68
2.24
2.12
1.1
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
18
89
2.05
2.07
1.4
1.4
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
5
10
5.03
2.07
3.0
3.5
—
16.4
—
0
5
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
7
20
3.53
2.06
1.6
3.5
umol/l
29.3
39.0
—
7
14
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
56
2.35
2.06
1.2
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
173
1434
1.28
2.04
2.4
2.0
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
15
4.03
2.04
4.3
6.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
25
140
1.82
2.03
1.9
1.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
32
2.84
2.00
7.0
2.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
15
70
2.17
1.99
2.4
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
25
141
1.80
1.99
2.1
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
53
364
1.50
1.98
2.9
1.8
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
51
2.38
1.96
1.5
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
51
2.38
1.96
1.5
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
53
366
1.49
1.94
2.9
1.8
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
6
16
3.77
1.94
1.5
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
159
1313
1.28
1.93
4.8
3.5
estimate
0.0
0.0
0.80
61
491
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
85
2.03
1.92
6.7
4.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
107
839
1.33
1.90
1.3
1.3
iu/ml
41.3
27.0
0.31
32
248
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
12
52
2.33
1.88
1.5
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
52
2.33
1.88
1.5
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
12
52
2.33
1.88
1.5
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
52
2.33
1.88
1.5
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
12
52
2.33
1.88
1.1
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
53
369
1.48
1.87
2.9
1.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
28
2.88
1.86
1.4
1.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
13
59
2.23
1.85
1.5
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
17
3.55
1.84
2.0
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
17
3.55
1.84
2.0
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
14
66
2.15
1.83
1.4
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
12
4.19
1.82
5.0
2.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
535
5091
1.32
1.80
31.3
12.7
%
39.5
39.9
0.73
456
4093
(3003327) Ova and parasites identified in Stool by Light microscopy
36
232
1.58
1.80
1.6
1.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
7
23
3.07
1.80
1.3
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
21
359
0.57
1.78
1.8
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
22
124
1.80
1.78
1.5
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
195
0.45
1.75
1.4
1.4
—
—
—
0
0
(4024509)
8
30
2.69
1.73
1.4
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
30
2.69
1.73
1.3
1.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
16
82
1.98
1.71
1.3
1.2
u/ml
5.1
3.6
—
8
34
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
42
286
1.50
1.67
2.6
2.1
ug/l
11.0
6.7
0.33
34
248
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
20
112
1.81
1.66
1.3
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
18
98
1.86
1.63
2.2
1.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
18
98
1.86
1.63
1.2
1.1
iu/ml
351.7
149.0
—
6
28
(3014148) Varicella zoster virus Ab [Titer] in Serum
18
99
1.84
1.58
1.2
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
20
3.02
1.58
1.5
4.8
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
612
5977
1.63
1.58
36.4
16.8
e9/l
6.8
6.7
1.05
607
5794
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
13
64
2.05
1.55
1.2
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
86
1.88
1.51
1.3
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
23
139
1.68
1.50
2.0
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
58
2.09
1.50
3.4
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
33
219
1.53
1.49
1.3
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
25
156
1.63
1.46
1.2
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
49
355
1.41
1.45
3.5
4.6
%
1.1
0.4
0.64
14
85
(3002256) Pathology report gross observation
72
556
1.33
1.44
1.4
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
59
2.05
1.44
1.3
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
22
2.74
1.43
1.3
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
23
141
1.65
1.43
2.3
3.7
umol/l
10.4
8.6
0.12
17
112
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
157
1.62
1.42
1.2
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
50
365
1.40
1.42
3.0
1.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
19
111
1.73
1.40
1.2
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
29
190
1.55
1.40
1.4
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
16
89
1.82
1.38
2.8
2.4
%
19.2
17.0
—
9
42
(3019225) pH of Specimen
50
367
1.39
1.38
7.7
4.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
41
2.21
1.37
1.0
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
41
2.21
1.37
1.0
1.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
41
2.21
1.37
1.9
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
41
2.21
1.37
1.0
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
23
2.62
1.37
1.0
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
23
2.62
1.37
1.0
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
23
2.62
1.37
1.0
1.9
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
6
23
2.62
1.37
1.7
1.9
—
1224630.0
—
0
5
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
23
2.62
1.37
1.0
1.9
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
15
82
1.85
1.36
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
25
159
1.60
1.36
1.2
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
17
2.96
1.36
1.0
2.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
17
2.96
1.36
2.0
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
17
2.96
1.36
1.0
2.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
17
2.96
1.36
2.0
1.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
17
2.96
1.36
1.0
2.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
10
47
2.15
1.34
1.3
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
11
54
2.06
1.33
1.3
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
48
353
1.39
1.32
3.6
5.0
%
0.0
0.0
0.99
13
92
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
23
145
1.61
1.30
2.5
1.9
iu/l
4.3
6.4
—
9
52
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
31
210
1.50
1.30
2.7
2.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
18
2.79
1.28
1.8
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
62
1.95
1.28
1.0
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
55
2.02
1.28
2.4
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
44
2.06
1.27
1.4
1.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
8
35
2.30
1.27
1.4
1.5
ug/l
7.7
7.2
—
8
29
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
25
2.41
1.24
6.3
2.4
ug/l
117.0
121.0
—
6
25
(3044242) Glucose [Moles/volume] in Arterial blood
6
25
2.41
1.24
2.0
4.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
12
63
1.92
1.23
1.4
1.6
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
5
19
2.64
1.22
9.8
7.9
—
—
—
0
0
(3012501) Base excess in Blood by calculation
17
101
1.70
1.21
3.2
5.3
mmol/l
1.7
2.7
0.97
11
60
(3042631) Mycobacterium sp identified in Specimen
8
39
2.06
1.15
2.0
3.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
39
2.06
1.15
1.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
20
2.51
1.15
1.0
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
51
390
1.33
1.13
3.6
4.8
%
0.6
0.8
0.29
16
122
(44790048)
14
81
1.74
1.09
2.5
1.7
—
—
—
0
0
(44806118)
14
81
1.74
1.09
2.5
1.7
—
—
—
0
0
(44790047)
14
81
1.74
1.09
2.5
1.7
—
—
—
0
0
(44790049)
14
81
1.74
1.09
2.5
1.7
—
—
—
0
0
(3004451) EKG impression Narrative
5
21
2.39
1.09
1.0
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
41
1.96
1.09
1.4
1.1
—
—
—
0
0
(4146454)
7
33
2.13
1.06
1.7
2.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
67
1.81
1.05
7.6
3.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
47
360
1.33
1.04
1.3
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
46
1.97
1.04
1.0
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
30
213
1.43
1.03
1.5
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
22
2.28
1.03
1.2
1.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
9
47
1.93
1.02
2.7
2.8
nmol/l
7.7
3.4
—
9
47
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
47
1.93
1.02
1.1
1.8
pg
30.0
33.5
—
9
47
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
16
99
1.63
1.00
4.4
2.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
5
23
2.18
0.98
2.4
1.6
u/l
11.0
4.4
—
5
11
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
23
2.18
0.98
1.0
1.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
7
36
1.95
0.97
1.1
1.1
—
—
—
0
0
(4268621)
10
54
1.87
0.97
2.1
2.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
21
303
0.68
0.94
1.3
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
46
579
0.78
0.88
2.0
1.9
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
43
1.87
0.87
1.1
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
44
1.83
0.86
1.6
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
14
88
1.60
0.85
2.2
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
45
1.79
0.84
1.6
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
59
482
1.25
0.83
6.5
5.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
81
685
1.21
0.83
3.5
2.5
mmol/l
2.5
2.4
0.30
72
586
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
172
1.41
0.82
1.5
2.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
32
1.88
0.82
1.5
1.6
g/l
0.8
1.1
—
6
32
(3019832) Treponema pallidum Ab [Presence] in Serum
77
907
0.83
0.82
1.8
1.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
46
367
1.27
0.79
3.8
4.9
%
0.3
0.2
0.26
16
109
(3000492) Spirometry study
58
476
1.24
0.79
1.5
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
26
191
1.38
0.78
1.4
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
133
1182
1.16
0.77
2.2
1.7
—
—
—
0
0
(4211845)
5
25
2.01
0.73
9.2
3.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
68
1.63
0.72
2.4
1.3
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
5
27
1.86
0.68
2.0
2.9
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
42
1.67
0.68
1.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
43
1.63
0.67
1.0
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
2.0
1.3
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
5
30
1.67
0.61
1.0
1.4
e6/l
738400.0
18893.6
—
5
19
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
13
88
1.49
0.61
1.3
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
176
1622
1.12
0.60
1.9
1.8
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
2.1
—
1.0
—
0
16
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
228
1.28
0.59
1.2
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
35
1.72
0.58
9.0
2.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
35
1.72
0.58
9.0
2.8
—
—
—
0
0
(4034850)
10
149
0.67
0.57
3.7
8.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
73
1.52
0.56
1.2
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
92
818
1.15
0.56
1.3
1.2
u/ml
6.4
9.0
0.26
29
318
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
58
497
1.18
0.56
4.6
3.8
%
33.5
31.3
0.72
39
341
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
37
1.63
0.55
1.2
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
61
1.48
0.54
1.1
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
120
1089
1.13
0.54
5.2
3.3
kg/l
1.0
1.0
0.09
21
142
(3020891) Body temperature
18
134
1.35
0.53
6.3
5.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
6
100
0.60
0.52
10.7
3.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
200
1875
1.10
0.49
4.8
3.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
178
0.72
0.49
1.8
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
41
345
1.20
0.49
2.6
2.1
e9/l
4.6
4.0
0.78
33
290
(44813793)
7
50
1.40
0.45
1.0
1.1
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
5
31
1.62
0.43
11.8
8.4
mmol/l
0.6
0.6
—
5
31
(3044927) Protein electrophoresis panel - Urine
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
5
32
1.57
0.42
1.0
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
32
1.57
0.42
1.0
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
58
1.38
0.41
1.6
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
33
1.52
0.41
1.4
1.2
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
5
34
1.47
0.40
2.2
1.2
nmol/l
13.3
41.7
—
5
28
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
71
1.41
0.39
1.9
1.5
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
18
145
1.25
0.34
1.4
1.3
—
23.0
—
0
7
(4027681)
6
47
1.28
0.32
1.3
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
47
1.28
0.32
2.5
4.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
47
1.28
0.32
1.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
11
83
1.33
0.32
1.0
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
458
4491
1.07
0.31
4.4
3.7
mmol/l
6.2
5.7
4.00
420
4112
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
92
991
0.92
0.31
1.5
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
17
138
1.24
0.30
1.5
1.3
—
17.1
—
0
24
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
25
292
0.85
0.29
1.6
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
119
1118
1.08
0.29
2.4
2.3
—
—
—
0
0
(1002224) Polysomnography panel
22
185
1.20
0.29
1.1
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
7
56
1.25
0.29
35.3
4.1
mmol/l
5.7
6.1
—
7
45
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
437
4284
1.06
0.29
4.0
3.6
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
14
112
1.26
0.28
1.4
1.3
—
31.7
—
0
10
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
117
0.77
0.27
2.2
1.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
44
397
1.12
0.25
2.5
2.3
u/l
10144.9
3869.3
0.43
12
151
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
75
1.20
0.25
1.2
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
48
436
1.11
0.25
1.0
1.1
—
—
—
0
0
(3013512) EKG study
117
1109
1.07
0.24
4.8
3.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
75
699
1.08
0.23
2.2
1.9
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
38
1.32
0.23
11.2
19.6
nmol/l
1306.4
1476.7
—
5
38
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
39
1.28
0.23
4.8
3.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
41
1.22
0.22
1.4
1.9
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(4133840)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
24
270
0.88
0.19
1.5
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
23
259
0.88
0.19
1.1
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
22
194
1.14
0.18
1.1
1.2
u/ml
0.5
1.7
0.82
12
118
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
24
269
0.89
0.18
1.5
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
60
1.17
0.18
2.3
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
14
120
1.17
0.16
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
14
120
1.17
0.16
1.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
81
1.11
0.15
1.0
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
107
1029
1.05
0.15
2.3
2.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
90
863
1.05
0.14
4.9
4.5
ug/l
1.7
2.5
1.16
79
772
(3003888) Timothy IgE Ab [Units/volume] in Serum
22
201
1.10
0.11
1.1
1.2
u/ml
5.5
9.1
0.40
15
130
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
25
270
0.92
0.11
1.5
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
117
1203
0.97
0.10
5.3
4.8
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
25
269
0.93
0.10
1.5
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
44
1.14
0.10
1.4
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
45
1.11
0.10
1.2
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
45
1.11
0.10
1.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
47
1.06
0.09
1.4
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
20
217
0.92
0.09
1.5
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
143
1400
1.03
0.08
4.3
3.0
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
15
136
1.11
0.08
2.5
1.5
nmol/l
44.5
37.9
0.36
15
131
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
6
57
1.05
0.08
1.2
1.2
u/l
14.0
15.0
—
6
50
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
10
112
0.89
0.07
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
96
937
1.03
0.07
1.7
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
84
1.07
0.07
1.6
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
86
1.05
0.07
1.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
20
213
0.94
0.06
1.5
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
14
129
1.09
0.05
1.1
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
20
212
0.94
0.05
1.5
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
109
0.92
0.04
2.5
3.9
%
56.2
54.8
—
10
109
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
55
563
0.97
0.04
2.0
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
168
1665
1.01
0.03
1.6
1.6
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
11
118
0.93
0.03
1.1
1.1
u/ml
0.7
1.1
—
6
35
(4094501)
10
93
1.08
0.02
1.0
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
107
0.93
0.02
2.4
3.5
e9/l
4.4
4.1
—
10
107
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
49
497
0.98
0.01
3.2
2.9
ug/l
0.6
0.8
0.98
39
306
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
23
236
0.97
0.00
2.3
2.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
45
456
0.99
0.00
5.8
3.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
12
115
1.04
0.00
1.2
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
22
225
0.98
0.00
1.1
1.2
u/ml
0.6
2.4
1.26
15
121
(3010726) Horse dander IgE Ab [Units/volume] in Serum
19
194
0.98
0.00
1.2
1.1
u/ml
1.4
3.7
—
8
49
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
25
254
0.98
0.00
1.0
1.4
miu/ml
119.6
265.2
0.99
11
131
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
69
685
1.01
0.00
3.8
4.1
%
22.8
21.6
0.22
31
318
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
138
1.01
0.00
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
101
0.99
0.00
1.0
1.2
—
—
—
0
0
(44806420)
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
8
0.00
0.00
0.0
10.8
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
8
0.00
0.00
0.0
2.8
—
4.3
—
0
8
(3032773) Endomysium IgG Ab [Titer] in Serum
8
87
0.92
0.00
1.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022670) pH of Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
51.6
—
0
6
(4038314)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
7
0.00
0.00
0.0
2.1
—
10411.4
—
0
7
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
2.2
—
9.6
—
0
5
(3044009) aPTT.lupus sensitive (LA screen)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
52
0.96
0.00
6.0
1.6
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
2.6
—
0.6
—
0
5
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
9
0.00
0.00
0.0
3.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_PHYSBEHOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_PHYSBEHOTH | 3.716 [3.0, 4.6] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.041 |
During the follow-up period (1.1.1998 — 31.12.2019), 316 out of 2207 females with F5_PHYSBEHOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_PHYSBEHOTH | 3.261 [2.58, 4.12] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 261 out of 1537 males with F5_PHYSBEHOTH died.
Mortality risk
Mortality risk for people of age
years, who have F5_PHYSBEHOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.399% | 0.601% |
| 5 | 1.878% | 3.387% |
| 10 | 4.839% | 8.455% |
| 15 | 9.05% | 15.842% |
| 20 | 15.128% | 25.809% |
Relationships between endpoints
↥Index endpoint: F5_PHYSBEHOTH – Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data